Cor Vasa 2011, 53(11):605-610 | DOI: 10.33678/cor.2011.154

Possibilities of optical coherence tomography in assessment of stent healing

Ota Hlinomaz1,*, Ladislav Groch1, Jan Sitar1, Michal Rezek1, Anna Kiliánová1, Martin Novák1, Jiří Seménka1, Toni Vekov2
1 I. interní kardioangiologická klinika, ICRC, FN u sv. Anny, Lékařská fakulta Masarykovy univerzity, Brno, Česká republika
2 Bulgarian Cardiac Institute, Sofie, Bulharsko

Optical coherence tomography is a new, very fast developing method in interventional cardiology. It gives us the opportunity to assess the inner structures of coronary artery wall, to evaluate the characteristics of atherosclerotic plaques, quality of stent implantation and its healing. The authors present current knowledge of optical coherence tomography and their own experience with this method.

Keywords: Optical coherence tomography; atherosclerotic plaque; stent healing; Malaposition

Published: November 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hlinomaz O, Groch L, Sitar J, Rezek M, Kiliánová A, Novák M, et al.. Possibilities of optical coherence tomography in assessment of stent healing. Cor Vasa. 2011;53(11):605-610. doi: 10.33678/cor.2011.154.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Huang D, Swanson EA, Lin CP, et al. Optical coherent tomography. Science 1991;254:1178-1181. Go to original source... Go to PubMed...
    2. Prati F, Regar E, Mintz GS, et al. Imaging of atherosclerosis: optical coherence tomography (OCT). Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J 2010;31:401-415. Go to original source... Go to PubMed...
    3. Špaček R, Červinka P. Nové možnosti zobrazení koronárních tepen - optická koherentní tomografie. Cor Vasa 2009;51(Suppl 1):43-46. Go to original source...
    4. Regar E, Ligthart J, Bruining N, van Soest G. The diagnostic value of intra-coronary optical coherence tomography. Herz 2011;36:417-429. Go to original source... Go to PubMed...
    5. Hong MK, Mintz GS, Lee CW et al. Late stent malaposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 2006;113:414-419. Go to original source... Go to PubMed...
    6. Tanigawa J, Barlis P, Kaplan S, Goktekin OCD. Stent strup apposition in complex lesions using optical coherence tomography. Am J Cardiol 2006; 98(Suppl 1):97M
    7. Radu M, Jørgensen E, Kelbaek H, et al. Optical coherence tomography at follow-up after percutaneous coronary intervention: relationship between procedural dissections, stent strut malapposition and stent healing. EuroIntervention 2011;7:353-361. Go to original source... Go to PubMed...
    8. Reimers B, Nikas D, Stabile E, et al. Preliminary experience with optical coherence tomography imaging to evaluate carotid artery stents: safety, feasibility and techniques. EuroIntervention 2011;7:98-105. Go to original source... Go to PubMed...
    9. Liu Y, Imanishi T, Kubo T, et al. Assessment by optical coherence tomography of stent struts across side branch. Comparison of bare-metal stents and drug-elution stents. Circ J 2010;75:106-112. Go to original source...
    10. Murata A, Wallace-Bradley D, Tellez A, et al. Accuracy of optical coherent tomography in the evaluation of neointimal coverage after stent implantation. JACC Cardiovasc Imaging 2010;3:76-84. Go to original source... Go to PubMed...
    11. Suzuki Y, Ikeno F, Koizumi T, et al. In vivo comparison between optical coherent tomography and intravascular ultrasound for detecting small degrese of in-stent neointima after stent implantation. JACC Cardiovasc Interv 2008;1:168-173. Go to original source... Go to PubMed...
    12. Capodanno D, Prati F, Pawlowsky T, et al. Comparison of optical coherence tomography and intravascular ultrasound for the assessment of in-stent tissue coverage after stent implantation. EuroIntervention 2009;5:538-543. Go to original source... Go to PubMed...
    13. www.medis.nl
    14. Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelization. Circulation 2007;115:2435-2441. Go to original source... Go to PubMed...
    15. Li S, Wang Y, Gai L, et al. Evaluation of neointimal coverage and apposition with various drug-eluting stents over 12 months after implantation by optical coherence tomography. Int J Cardiol 2011;doi:10.1016/j.ijcard.2011.05.076 Go to original source... Go to PubMed...
    16. Fujii K, Kawasaki D, Oka K, et al. Endothelium-dependent coronary vasomotor response and neointimal coverage of zotarolimus-eluting stents 3 months after implantation. Heart 2011;97:977-982. Go to original source... Go to PubMed...
    17. Inoue T, Shite J, Yoon J, et al. Optical coherence evaluation of everolimus-eluting stents 8 months after implantation. Heart 2011;97:1379-1384. Go to original source... Go to PubMed...
    18. Guagliumi G, Sirbu V, Musumeci G, et al. Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI). Circ Cardiovasc Interv 2010;3:367-375. Go to original source... Go to PubMed...
    19. La Manna A, Capodanno D, Cera M, et al. Optical coherence tomographic results at six-month follow-up evaluation of the CATANIA coronary stent system with nanothin Polyzene-F surface modification (from the Assessment of The LAtest Non-Thrombogenic Angioplasty Stent [ATLANTA] trial). Am J Cardiol 2009;103:1551-1555. Go to original source... Go to PubMed...
    20. La Manna A, Prati F, Capodanno D, et al. Head-to-head comparison of early vessel healing by optical coherence tomography after implantation of different stents in the same patient. J Cardiovasc Med 2011;12:328-333. Go to original source... Go to PubMed...
    21. Kubo T, Imanishi T, Kitabata H, et al. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. JACC Cardiovasc Imaging 2008;1:475-484. Go to original source... Go to PubMed...
    22. Templin C, Meyer M, Muller MF, et al. Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy. Eur Heart J 2010;31:1792-1801. Go to original source... Go to PubMed...
    23. Tahara S, Bezerra HG, Sirbu V, et al. Angiographic, IVUS and OCT evaluation of the long-term impact of coronary disease severity at the site of overlapping drug-eluting and bare metal stents: a substudy of the ODESSA trial. Heart 2010;96:1574-1578. Go to original source... Go to PubMed...
    24. Guagliumi G, Musumeci G, Sirbu V, et al. Optical coherence tomography assessment of in vivo vascular response following implantation of overlapping bare-metal and drug-eluting stents. JACC Cardiovasc Interv 2010;3:531-539. Go to original source... Go to PubMed...
    25. Katoh H, Shite J, Shinke T, et al. Delayed neontimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography. Circ J 2009;73:1033-1037. Go to original source... Go to PubMed...
    26. Kim JS, Jang IK, Fan C, et al. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial. JACC Cardiovasc Interv 2009;2:1240-1247. Go to original source... Go to PubMed...
    27. Kim JS, Fan C, Choi D, et al. Different patterns of neointimal coverage between acute coronary syndrome and stable angina after various types of drug-eluting stents implantation; 9-month follow-up optical coherence tomography study. Int J Cardiol 2011;146:341-346. Go to original source... Go to PubMed...
    28. Guagliumi G, Musumeci G, Sirbu V, et al. Optical coherence tomography assessment of in vivo vascular response following implantation of overlapping bare-metal and drug-eluting stents. JACC Cardivasc Interv 2010;3:531-539. Go to original source... Go to PubMed...
    29. Ughi GJ, Adriaenssens T, Onsea K, et al. Automatic segmentation of in-vivo intra-coronary optical coherence tomography images to assess stent strut apposition and coverage. Int J Cardiovasc Imaging 2011;doi:10.1007/s10554-011-9284-3. Go to original source... Go to PubMed...
    30. Barlis P, Regar E, Serruys PW, et al. An optical coherence tomography study of a biodegradable vs durable polymer-coated limus-eluting stent: a LEADERS trial substudy. Eur Heart J 2010;31:165-176. Go to original source... Go to PubMed...
    31. Guagliumi G, Sirbu V, Costa MS, et al. Long-term strut coverage of paclitaxel eluting stents compared to bare-metal stents implanted during primary PCI in acute myocardial infarction: HORIZONS-OCT. Circulation 2011;123:274-281. Go to original source... Go to PubMed...
    32. Guagliumi G, Sirbu V, Bezerra HG, et al. Strut coverage and vessel wall response to zotarolimus-eluting and bare metal stents implanted in patients with ST-elevation myocardial infarction: the OCTAMI study. JACC Cardiovasc Interv 2010;3:680-687. Go to original source... Go to PubMed...
    33. www.clinicaltrials.gov
    34. Tahara S, Chamié D, Baibars M, et al. Optical coherence tomography endpoints in stent clinical investigations: strut coverage. Int J Cardiovasc Imaging 2011;27:271-287. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes